CROI 2023


The Conference on Retroviruses and Opportunistic Infections (CROI) took place February 19-22 at the Summit Convention Center in Seattle. HPTN researchers presented eight abstracts covering HPTN 071, HPTN 083, HPTN 084, HPTN 084-01, and the HPTN Modelling Centre.





Monday, February 20



Population Impact of Expanding PrEP Usage in South Africa: Model Comparison Analysis

Sarah Stansfield Poster

Tuesday, February 21

HPTN 071

HIV Incidence Differences Measured by Serial Cross-Sectional

Incidence Testing: HPTN 071 (PopART)
Oliver Laeyendecker Oral
HPTN 084

Cabotegravir Pharmacology in The Background of Delayed Injections in HPTN 084

Mark Marzinke Oral
HPTN 083 and HPTN 084

The LEVI Syndrome: Characteristics of Early HIV Infection with Cabotegravir for PrEP

Susan Eshleman Oral
HPTN 083

Cabotegravir for HIV PrEP in U.S. Black Men and Transgender Women Who Have Sex with Men

Hyman Scott Oral
HPTN 084-01

CAB-LA for HIV Prevention in African Cisgender Female Adolescents

Sybil Hosek

HPTN 083

Pre-Exposure Prophylaxis Product Choice in U.S. Participants in HPTN 083

Meredith Clement


Wednesday, February 22

HPTN 083

Bone Density Changes with CAB-LA or TDC/FTC PrEP in MSM and TGW in HPTN 083

Todd Brown